These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10661871)

  • 1. Comparison of the tamoxifen regulated chimeric Cre recombinases MerCreMer and CreMer.
    Verrou C; Zhang Y; Zürn C; Schamel WW; Reth M
    Biol Chem; 1999 Dec; 380(12):1435-8. PubMed ID: 10661871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Floxed reporter genes: Flow-cytometric selection of clonable cells expressing high levels of a target gene after tamoxifen-regulated Cre-loxP recombination.
    Spiotto MT; Schreiber H
    J Immunol Methods; 2006 May; 312(1-2):201-8. PubMed ID: 16674971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A tamoxifen-inducible chimeric Cre recombinase specifically effective in the fetal and adult mouse liver.
    Tannour-Louet M; Porteu A; Vaulont S; Kahn A; Vasseur-Cognet M
    Hepatology; 2002 May; 35(5):1072-81. PubMed ID: 11981757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse.
    Hayashi S; McMahon AP
    Dev Biol; 2002 Apr; 244(2):305-18. PubMed ID: 11944939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ER-based double iCre fusion protein allows partial recombination in forebrain.
    Casanova E; Fehsenfeld S; Lemberger T; Shimshek DR; Sprengel R; Mantamadiotis T
    Genesis; 2002 Nov; 34(3):208-14. PubMed ID: 12395386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2.
    Hirrlinger PG; Scheller A; Braun C; Hirrlinger J; Kirchhoff F
    Glia; 2006 Jul; 54(1):11-20. PubMed ID: 16575885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conditional gene activation in cultured hepatocytes using a ligand-dependent chimeric Cre recombinase.
    Zhu HZ; Cao YY; Cheng GX; Xue JL
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 May; 35(5):435-40. PubMed ID: 12766804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of Cre recombinase toxicity in proliferating Drosophila cells by estrogen-dependent activity regulation.
    Heidmann D; Lehner CF
    Dev Genes Evol; 2001 Sep; 211(8-9):458-65. PubMed ID: 11685583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducible site-directed recombination in mouse embryonic stem cells.
    Zhang Y; Riesterer C; Ayrall AM; Sablitzky F; Littlewood TD; Reth M
    Nucleic Acids Res; 1996 Feb; 24(4):543-8. PubMed ID: 8604292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site- and time-specific gene targeting in the mouse.
    Metzger D; Chambon P
    Methods; 2001 May; 24(1):71-80. PubMed ID: 11327805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal control of Cre recombinase-mediated in vitro DNA recombination by Tet-on gene expression system.
    Guo ZM; Xu K; Yue Y; Huang B; Deng XY; Zhong NQ; Hong X; Chen XG; Xiao D
    Acta Biochim Biophys Sin (Shanghai); 2005 Feb; 37(2):133-8. PubMed ID: 15685371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-contamination with tamoxifen induces transgene expression in non-exposed inducible transgenic mice.
    Brake RL; Simmons PJ; Begley CG
    Genet Mol Res; 2004 Dec; 3(4):456-62. PubMed ID: 15688312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering cell-permeant FLP recombinase for tightly controlled inducible and reversible overexpression in embryonic stem cells.
    Patsch C; Peitz M; Otte DM; Kesseler D; Jungverdorben J; Wunderlich FT; Brüstle O; Zimmer A; Edenhofer F
    Stem Cells; 2010 May; 28(5):894-902. PubMed ID: 20333748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeras of the Flp and Cre recombinases: tests of the mode of cleavage by Flp and Cre.
    Shaikh AC; Sadowski PD
    J Mol Biol; 2000 Sep; 302(1):27-48. PubMed ID: 10964559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient recombination in pancreatic islets by a tamoxifen-inducible Cre-recombinase.
    Zhang H; Fujitani Y; Wright CV; Gannon M
    Genesis; 2005 Jul; 42(3):210-7. PubMed ID: 15986486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A practical summary of site-specific recombination, conditional mutagenesis, and tamoxifen induction of CreERT2.
    Anastassiadis K; Glaser S; Kranz A; Berhardt K; Stewart AF
    Methods Enzymol; 2010; 477():109-23. PubMed ID: 20699139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell type-specific conditional regulation of the c-myc proto-oncogene by combining Cre/loxP recombination and tamoxifen-mediated activation.
    Jäger R; Maurer J; Jacob A; Schorle H
    Genesis; 2004 Mar; 38(3):145-50. PubMed ID: 15048812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene transfer and genetic modification of embryonic stem cells by Cre- and Cre-PR-expressing MESV-based retroviral vectors.
    Psarras S; Karagianni N; Kellendonk C; Tronche F; Cosset FL; Stocking C; Schirrmacher V; Boehmer Hv Hv; Khazaie K
    J Gene Med; 2004 Jan; 6(1):32-42. PubMed ID: 14716675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inducible gene inactivation in neurons of the adult mouse forebrain.
    Erdmann G; Schütz G; Berger S
    BMC Neurosci; 2007 Aug; 8():63. PubMed ID: 17683525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. F9 embryonal carcinoma cells engineered for tamoxifen-dependent Cre-mediated site-directed mutagenesis and doxycycline-inducible gene expression.
    Chiba H; Chambon P; Metzger D
    Exp Cell Res; 2000 Nov; 260(2):334-9. PubMed ID: 11035928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.